Anshan Hifichem Co., Ltd.
300758.SZ · SHZ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -8.41 | -2.25 | 0.07 | -2.82 |
| FCF Yield | 0.28% | -1.10% | -1.09% | 0.16% |
| EV / EBITDA | 190.02 | 169.15 | 109.76 | 294.66 |
| Quality | ||||
| ROIC | 0.91% | 0.79% | 1.20% | 0.22% |
| Gross Margin | 29.49% | 31.07% | 32.83% | 39.41% |
| Cash Conversion Ratio | 1.85 | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 9.48% | 11.46% | 11.81% | 8.97% |
| Free Cash Flow Growth | 124.32% | -16.21% | -802.79% | -75.71% |
| Safety | ||||
| Net Debt / EBITDA | 26.00 | 11.53 | 7.32 | 22.97 |
| Interest Coverage | 3.02 | 2.06 | 3.40 | 0.79 |
| Efficiency | ||||
| Inventory Turnover | 0.60 | 0.67 | 0.57 | 0.65 |
| Cash Conversion Cycle | 211.72 | 189.34 | 217.08 | 63.93 |